AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
Novo Nordisk, Eli Lilly and the GLP-1 economy
Unhedged
The Competitive Landscape of Diabetes and Weight Loss Medications
This chapter explores the fierce competition between two leading pharmaceutical companies in the diabetes and weight loss drug market. It examines their historical rivalry, stock performance, and the societal implications of GLP-1 medications, including off-label prescription practices.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode